Mikkel Bandak
Papers
1
Total Citations
14
H-Index
1
About
Mikkel Bandak is a dedicated clinical researcher whose work centers on the surgical management of testicular cancer, specifically non-seminomatous germ cell tumours. His major contribution lies in systematically evaluating the oncological outcomes and complications of post-chemotherapy retroperitoneal lymph node dissection (RPLND), a critical but high-risk procedure for patients with residual retroperitoneal masses. His 2021 systematic review, which has garnered 14 citations, provides essential evidence on recurrence rates and surgical complications, helping to refine treatment protocols and improve patient counseling. This work is particularly notable for its focus on bilateral RPLND, a technically demanding operation. By synthesizing data on both efficacy and safety, Bandak’s research directly supports urologic oncologists in making informed decisions about post-chemotherapy surgery. His findings are vital for balancing the need for complete tumor resection against the risk of morbidity, ultimately advancing the standard of care for young men facing this challenging disease.
Research Focus
Key Achievements
Top Papers
- 1